Business
Novartis strikes deal with UK biotech for up to US$1.7 billion
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Novartis will pay UK biotech…
Tag
Biotech
Business
Biotech company Amgen set to build $600-million research center in Thousand Oaks
Biotech company Amgen is investing $600 million into a new research center for its Thousand Oaks campus. The new site will create hundreds…
Business
China’s biotech moment ignites a 60% stock rally that beats AI
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds are tipping…
Business
Merck held talks to buy biotech MoonLake for over US$3 billion: FT
K has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times reported on Monday,…
Business
Singapore-based biotech firm Nuevocor raises US$45 million in Series B round
Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new and…
News
LA Biotech Investor Convicted in Murder-for-Hire Plot of Vermont Partner Who Threatened to Report Him to Authorities Over Fraud
A federal jury has convicted the accused mastermind behind a murder-for-hire plot of all charges brought against him in the 2018 killing…
Business
Initial MAS review group incentives could pull in regional biotech, fintech players: observers
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too MARKET watchers…
Business
MAS review group incentives could pull in regional biotech, fintech players: observers
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too MARKET watchers…
Business
GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion…
Business
Johnson & Johnson is in talks to buy US$10 billion biotech Intra-Cellular
JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments for central…